ANROVSSTDN• 3 Months (Normalized)
ANRO vs STDN (Alto Neuroscience Inc. vs Standard Nuclear Inc.)
Showing Closing Date Range from Jul 9 to Oct 7, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
ANRO Performance $23.52
-14.91%
Alto Neuroscience Inc.
Normalized Baseline0.00%
STDN Performance $14.21
+15.53%
Standard Nuclear Inc.
Normalized Baseline0.00%
Alpha Spread Margin STDN LEADS
-30.44 pts
STDN outperforming by 30.44 percentage points
ANROSTDN
Spread Trajectory3 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
ANRO STDN
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(63 dates)
| Date | ANRO Price | ANRO Gain (%) | STDN Price | STDN Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 07, 2026 | $23.52 | -14.91% | $14.21 | +15.53% | -30.44% |
| Oct 06, 2026 | $23.69 | -14.29% | $15.19 | +23.50% | -37.79% |
| Oct 05, 2026 | $24.01 | -13.13% | $13.01 | +5.77% | -18.90% |
| Oct 02, 2026 | $24.80 | -10.27% | $12.52 | +1.79% | -12.06% |
| Sep 30, 2026 | $25.88 | -6.37% | $12.03 | -2.17% | -4.20% |
| Sep 29, 2026 | $26.58 | -3.84% | $12.02 | -2.28% | -1.56% |
| Sep 28, 2026 | $26.66 | -3.55% | $11.53 | -6.26% | +2.71% |
| Sep 25, 2026 | $26.49 | -4.16% | $12.34 | +0.33% | -4.49% |
| Sep 24, 2026 | $27.18 | -1.66% | $12.25 | -0.41% | -1.25% |
| Sep 23, 2026 | $27.50 | -0.51% | $12.85 | +4.47% | -4.98% |
| Sep 22, 2026 | $30.78 | +11.36% | $13.02 | +5.85% | +5.51% |
| Sep 21, 2026 | $30.63 | +10.82% | $13.50 | +9.76% | +1.06% |
| Sep 18, 2026 | $30.27 | +9.52% | $12.84 | +4.39% | +5.13% |
| Sep 17, 2026 | $30.98 | +12.08% | $12.49 | +1.54% | +10.54% |
| Sep 16, 2026 | $30.00 | +8.54% | $11.91 | -3.17% | +11.71% |
Page 1 of 5